Author | Mary Jo Fidler, MD | OncLive

Author | Mary Jo Fidler, MD

Articles

Dr. Fidler Discusses Osimertinib in EGFR-Mutated Lung Cancer

September 28, 2017

Video

Mary Jo Fidler, MD, associate professor, medical oncology, hematology, internal medicine, Rush University Medical Center, discusses osimertinib (Tagrisso) in patients with EGFR T790M-positive non–small cell lung cancer.

Dr. Mary Jo Fidler on the Role of Oligoclonal T Cell Expansion in NSCLC

October 26, 2016

Video

Mary Jo Fidler, MD, associate professor, medical oncology, hematology, internal medicine, Rush University Medical Center, discusses how early and persistent oligoclonal T cell expansion correlates with durable response to anti-PD1 therapy in non-small cell lung cancer treatment (NSCLC).

x